Skip to main content

Public Policy

By HIMSS TV | 07:00 am | December 08, 2023
Dr. Michael Howell, Google's chief clinical officer, discusses what federal regulators should consider while configuring rules around AI use in healthcare and how the company ensures health equity within its medically tuned LLM, Med-PaLM.  
By Jessica Hagen | 03:41 pm | December 05, 2023
Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.
By HIMSS TV | 07:00 am | November 20, 2023
Health systems' cybersecurity infrastructure is only as strong as its weakest third-party vendor, says chief healthcare officer at Ordr Wes Wright, and government should fund cybersecurity because it requires systems to have a digital footprint.
By Nathan Eddy | 06:24 pm | November 07, 2023
The AI-enabled hearing aids automatically adjust to an individual's hearing needs without configuration.
By HIMSS TV | 02:00 pm | October 31, 2023
Elise Kohl-Grant, cochair of the programming committee at the HIMSS New York State Chapter, discusses upcoming events at HIMSS and how the group incorporates diverse patient perspectives, especially regarding the utilization of technology.  
By HIMSS TV | 07:00 am | October 26, 2023
According to Daniel Stein, president of Stewards of Change, a fully interoperable central consent registry will allow everyone in the U.S. the right to choose how, and with whom, their personal and health data is shared.  
07:00 am | October 25, 2023
Ann Maxwell, deputy inspector general for evaluations at the U.S. Department of Health and Human Services Office of Inspector General, discusses the case for making the pandemic-related CMS telehealth expansion permanent.  
By Jessica Hagen | 01:37 pm | September 22, 2023
Jennifer Mathieu, senior vice president of professional and government affairs at AMCP, provides an update on the Access to Prescription Digital Therapeutics Act 2023 moving through Congress.
By Jessica Hagen | 12:18 pm | September 15, 2023
The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.